Alexza Pharmaceuticals

Acquired

Alexza.com

Public · Mountain View, United States · Founded 2002 · $124.5M raised

Employees
51–200
Founded
2002
Business Model
B2B
Website
alexza.com
Total Funding
$124.5M
Last Round
$20.0M Series DJul 2012
Rounds
4
Type
Public
Acquisition Date
May 2016

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 7 funding rounds and 8 investors for this company. The full record is or through the API.

About

Founded in 2000 and headquartered in Mountain View, California, Alexza Pharmaceuticals developed and commercialized products based on its proprietary Staccato system — a hand-held single-use inhaler delivering pure drug aerosols to the deep lung for rapid systemic delivery. Its lead commercial product was Adasuve (loxapine), an inhaled antipsychotic for acute agitation associated with schizophrenia or bipolar disorder. Alexza was acquired by Grupo Ferrer Internacional in June 2016 and now operates as part of the Ferrer group.

Summary

Alexza Pharmaceuticals is a Biotech company based in Mountain View, United States, founded in 2002. It has raised $124.5M in total across 4 rounds, most recently a $20.0M Series D round in Jul 2012. Investors include Azimuth Opportunity LP, Symphony Capital Partners and Atlas Venture.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding & Exit History

AcquisitionMay 2016

Sign up to see all 7 events

Funding: Series A through Series D. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Alexza Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/alexza-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/alexza-pharmaceuticals" alt="Alexza Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>